516 ian cancer cells. Carcinogenesis 2007;28:1153-62. 14. Kraunz KS, Nelson HH, Liu M, Wiencke JK, Kelsey KT. Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer. Br J Cancer 2005;93:949-52. 15. Hsu MY, Rovinsky S, Penmatcha S, Herlyn M, Muirhead D. Bone morphogenetic proteins in melanoma: angel or devil? Cancer Metastasis Rev 2005;24:251-63. 16. Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008;454: 1000-4. 17. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: track- ing obesity to its source. Cell 2007;131:242-56. 18. Sebald W, Nickel J, Zhang JL, Mueller TD. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol Chem 2004;385:697-710. 19. Miyazono K, Kusanagi K, Inoue H. Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol 2001;187:265-76. 20. Nohe A, Keating E, Knaus P, Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004;16:291-9. 21. Ito H, Akiyama H, Shigeno C, Nakamura T. Noggin and bone mor- phogenetic protein-4 coordinately regulate the progression of chondrogenic differentiation in mouse clonal EC cells, ATDC5. Biochem Biophys Res Commun 1999;260:240-4. 22. Zhu W, Kim J, Cheng C, Rawlins BA, Boachie-Adjei O, Crystal RG, et al. Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro. Bone 2006;39:61-71. 23. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, et al. Dorsomorphin inhibits BMP signals required for em- bryogenesis and iron metabolism. Nat Chem Biol 2008;4:33-41. 24. ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, et al. Characterization of type I receptors for transforming growth factor-beta and activin. Science 1994;264:101-4. 25. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A 1995;92:7632-6. 26. Derynck R, Zhang Y, Feng XH. Smads: transcriptional activators of TGF-beta responses. Cell 1998;95:737-40. 27. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, et al. The mode of bone morphogenetic protein (BMP) receptor oli- gomerization determines different BMP-2 signaling pathways. J Biol Chem 2002;277:5330-8. 28. Hassel S, Schmitt S, Hartung A, Roth M, Nohe A, Petersen N, et al. Initiation of Smad-dependent and Smad-independent signal- ing via distinct BMP-receptor complexes. J Bone Joint Surg Am 2003;85(A Suppl 3):44-51. 29. Canalis E, Economides AN, Gazzerro E. Bone morphogenetic pro- teins, their antagonists, and the skeleton. Endocr Rev 2003;24: 218-35. 30. Larrain J, Bachiller D, Lu B, Agius E, Piccolo S, De Robertis EM. BMP-binding modules in chordin: a model for signalling regu- lation in the extracellular space. Development 2000;127:821-30. 31. Miyazono K. Positive and negative regulation of TGF-beta signaling. J Cell Sci 2000;113:1101-9. 32. Stottmann RW, Anderson RM, Klingensmith J. The BMP antago- nists Chordin and Noggin have essential but redundant roles in mouse mandibular outgrowth. Dev Biol 2001;240:457-73. 33. Piccolo S, Agius E, Leyns L, Bhattacharyya S, Grunz H, Bouwmeester T, et al. The head inducer Cerberus is a multifunc- tional antagonist of Nodal, BMP and Wnt signals. Nature 1999; Korean J Urol 2010;51:511-517 Jeong et al 397:707-10. 34. Yokouchi Y, Vogan KJ, Pearse RV 2nd, Tabin CJ. Antagonistic signaling by Caronte, a novel Cerberus-related gene, establishes left-right asymmetric gene expression. Cell 1999;98:573-83. 35. Capdevila J, Johnson RL. Endogenous and ectopic expression of noggin suggests a conserved mechanism for regulation of BMP function during limb and somite patterning. Dev Biol 1998;197: 205-17. 36. Zhang D, Ferguson CM, O'Keefe RJ, Puzas JE, Rosier RN, Reynolds PR. A role for the BMP antagonist chordin in endochon- dral ossification. J Bone Miner Res 2002;17:293-300. 37. Tardif G, Pelletier JP, Boileau C, Martel-Pelletier J. The BMP an- tagonists follistatin and gremlin in normal and early osteo- arthritic cartilage: an immunohistochemical study. Osteoarthri- tis Cartilage 2009;17:263-70. 38. Michos O, Panman L, Vintersten K, Beier K, Zeller R, Zuniga A. Gremlin-mediated BMP antagonism induces the epithelial-mes- enchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 2004;131:3401-10. 39. Khokha MK, Hsu D, Brunet LJ, Dionne MS, Harland RM. Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet 2003;34:303-7. 40. Zimmerman LB, De Jesus-Escobar JM, Harland RM. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 1996;86:599-606. 41. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1998;1:673-83. 42. Haudenschild DR, Palmer SM, Moseley TA, You Z, Reddi AH. Bone morphogenetic protein (BMP)-6 signaling and BMP antago- nist noggin in prostate cancer. Cancer Res 2004;64:8276-84. 43. Tezval M, Tezval H, Dresing K, Stuermer EK, Blaschke M, Stuermer KM, et al. Differentiation dependent expression of ur- ocortin's mRNA and peptide in human osteoprogenitor cells: in- fluence of BMP-2, TGF-beta-1 and dexamethasone. J Mol Histol 2009;40:331-41. 44. Hanyu A, Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K. The N domain of Smad7 is essential for specific in- hibition of transforming growth factor-beta signaling. J Cell Biol 2001;155:1017-27. 45. Zhu HT, Kavsak P, Abdollah S, Wrana JL, Thomsen GH. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 1999;400:687-93. 46. Hata A, Lagna G, Massague J, Hemmati-Brivanlou A. Smad6 in- hibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Gene Dev 1998;12:186-97. 47. Zwijsen A, Verschueren K, Huylebroeck D. New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Lett 2003;546:133-9. 48. Dudley AT, Robertson EJ. Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev Dyn 1997;208:349-62. 49. Godin RE, Robertson EJ, Dudley AT. Role of BMP family mem- bers during kidney development. Int J Dev Biol 1999;43:405-11. 50. Dudley AT, Lyons KM, Robertson EJ. A requirement for bone mor- phogenetic protein-7 during development of the mammalian kid- ney and eye. Genes Dev 1995;9:2795-807. 51. Mitu G, Hirschberg R. Bone morphogenetic protein-7 (BMP7) in chronic kidney disease. Front Biosci 2008;13:4726-39. 52. Kim IY, Lee DH, Lee DK, Kim BC, Kim HT, Leach FS, et al.